首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Current gastroenterology reports

缩写:

ISSN:1522-8037

e-ISSN:1534-312X

IF/分区:4.1/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1168
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Alexander C Ford,Paul Moayyedi Alexander C Ford
The prevalence of dyspepsia in the general population is as high as 40%, and its management represents a considerable financial burden to the health care system. Causes of dyspepsia amenable to medical therapy include peptic ulcer and funct...
Satish S C Rao,Jorge T Go Satish S C Rao
Pelvic floor disorders that affect defecation consist of structural disorders (eg, rectocele) and functional disorders (eg, dyssynergic defecation). Evaluation includes a thorough history and physical examination, a careful digital rectal e...
Yvette Taché,Cornelia Kiank,Andreas Stengel Yvette Taché
Functional gastrointestinal disorders (FGIDs), which include irritable bowel syndrome (IBS), encompass a heterogeneous group of diseases identified by chronic or recurrent symptom-based diagnostic criteria. Psychosocial factors are key comp...
Brennan M R Spiegel Brennan M R Spiegel
Irritable bowel syndrome (IBS) is a prevalent and expensive condition that significantly impairs health-related quality of life (HRQOL) and reduces work productivity. Based on strict criteria, 7% to 10% of people have IBS worldwide. Communi...
Maria T Greene,Peter F Whitington Maria T Greene
Autoimmune hepatitis (AIH) is a common cause of acute and chronic hepatitis in childhood. Once the diagnosis is established, treatment with cortico-steroid or corticosteroid and azathioprine is indicated. Most children with AIH respond to s...
Ajay S Gulati,Marla C Dubinsky Ajay S Gulati
The intestinal microbiota plays a key role in the initiation and perpetuation of inflammatory bowel diseases (IBD). As such, there is a strong rationale to use agents such as probiotics to modulate the gut microbiome as a treatment strategy...